logo-loader
viewOxford Biodynamics PLC

'Interest is growing exponentially', says Oxford Biodynamics' Christian Hoyer Millar

Oxford Biodynamics (LON:OBD) CEO Christian Hoyer Millar and CSO Sasha Akoulitchev talk to Proactive's Andrew Scott about the company's platform EpiSwitch as well as the overall strategy and outlook.

Their technology manages biomarkers in people’s blood to help pharmaceutical companies identify which patients will react to certain drugs.

''We've worked with six of the biggest pharma and biotech companies in the world so far. We've undertaken about 23 projects and the interest in what we're doing is growing exponentially'', Hoyer Millar says.

Quick facts: Oxford Biodynamics PLC

Price: 93.35 GBX

AIM:OBD
Market: AIM
Market Cap: £86.4 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Condor Gold: Proactive analyst on site at La India project in Nicaragua

Proactive's Mining Analyst Dr Ryan Long updates on his site visit to Condor Gold’s (LON:CNR) 100%-owned La India Gold Project, located within the Leon Region of Nicaragua. The project covers the majority of the La India Gold District -  an impressive ground holding that Condor has put...

3 hours, 16 minutes ago

2 min read